Introduction
============

Since the 1980s there has been an increasing appreciation of the extent of adolescent low back pain (ALBP) in the community.[@b1-jpr-3-057]--[@b3-jpr-3-057] This shift in awareness appears to have resulted from a series of international epidemiological studies which identified a significant prevalence of reported spinal pain in otherwise 'healthy' adolescents.[@b4-jpr-3-057]--[@b6-jpr-3-057]

This increased awareness of the prevalence of ALBP is reflected in the increase in published research on ALBP over the past 30 years. For this paper, ALBP refers to low back pain present in adolescents, ie, between 10 and 19 years of age, of no known pathological cause. The published research related to ALBP can be characterized into two major streams. The first stream focuses on the prevalence of ALBP and the associated risk factors, whilst the second stream explores the clinical management of the adolescent presenting with low back pain. This paper focuses on the first of these streams, ie, observational studies which describe the prevalence of ALBP in specific population groups and the associated risk factors.

Despite an increasing number of observational studies into this common form of adolescent morbidity and associated factors, there remains little agreement on the risk factors.[@b7-jpr-3-057],[@b8-jpr-3-057] When presented with a number of observational studies, focused on the one condition, meta-analysis has been promoted as the best approach for combining the datasets.[@b9-jpr-3-057] However, valid meta-analysis depends on homogeneity of the included studies. When significant inter-study differences in methodologies exist, this hinders the ability to amalgamate datasets for analytical purposes.

Defining ALBP
-------------

Our preliminary reading highlighted the potential for a lack of homogeneity in the descriptors of ALBP. This paper reviews the definitions used in the literature related to ALBP prevalence. By describing the current situation in terms of the definitions of ALBP used, the foundation is set for further research in identifying a common classification system for use in ALBP. The terms used to present the details of research, in particular dependant variables such as ALBP, are important as they facilitate communication and common understanding.[@b10-jpr-3-057] To further highlight the effect of definitional differences on ALBP prevalence, the studies identified in this review were categorized into three broad subgroups, according to their definitions, and the relative prevalence of ALBP between these groups was compared using period prevalence rates.

Significant progress has been made in international recognition and understanding of ALBP, but two issues remain. The first issue, common to adult research, is the difficulty in arriving at an agreed diagnosis for the LBP.[@b11-jpr-3-057] The complexity of the spine, both anatomically and functionally, makes effective diagnosis difficult. Current clinical, surgical, and radiographic investigatory techniques are hampered as the pain-sensitive structures are often not amenable to direct anatomical scrutiny.[@b11-jpr-3-057] Although there are well-reported descriptions of a range of clinical presentations, an understanding of pain itself, in terms of etiology and pain mechanisms, is less well developed.[@b12-jpr-3-057]

In the adult population, over 50% of LBP sufferers have an unclear diagnosis, despite extensive laboratory and radiographic investigations.[@b13-jpr-3-057] In nine out of 10 cases, adult spinal pain has been described as transient, related to posture or strain, with recovery occurring in a short period of time.[@b14-jpr-3-057] Amongst the adult population, 60% to 80% will suffer an episode of LBP in their lifetime with a subset of 2% to 7% reporting ongoing chronic, recurrent pain.[@b15-jpr-3-057]

The second issue, related to etiology, is the range of potentially interdependent and time-dependent factors that influence the reporting of ALBP. These factors, which may present as risk factors or prognostic factors, affect the development and progression of the condition. The wide variation in timing and tempo of the developmental processes within an adolescent population further compounds the difficulty in identifying and categorizing these factors. Epidemiological studies play an important role in providing information on the etiology, natural history, impact of health conditions such as ALBP, and the interrelationships between potential risk and prognostic factors.[@b16-jpr-3-057]

These two issues are intrinsically linked to progressing the understanding of ALBP. The ability to identify causes of ALBP is dependent on the ability to accurately define and classify ALBP. It is naïve to consider that all forms of self-reported ALBP are the same and, likewise, optimistic to consider that all types of ALBP are caused by the same factors.

Observational studies into the prevalence of ALBP have generally avoided identifying a pathoanatomical cause for the pain. The etiology for the ALBP reported in these studies remains unknown, with the range of potential causes outlined in [Table 1](#t1-jpr-3-057){ref-type="table"}.

When attempting to understand the prevalence and the behavior of potential risk factors for a condition such as ALBP through observational studies, the first step is to classify the subjects who have the condition. In some conditions this classification process is self explanatory, often through the presence of a measurable biological marker, whilst in other conditions, such as ALBP, it is harder to define.

The measure most commonly collected is an adolescent's self-report of pain. However, self-reported pain can be described in multidimensional terms, using measures such as chronicity, frequency, episode duration,[@b19-jpr-3-057] intensity (ie, pain effects), severity (including effect on activities of daily living \[ADL\]),[@b16-jpr-3-057],[@b20-jpr-3-057] and recall prevalence. These measures are not mutually exclusive, with each describing an aspect of the pain experience. However, of these measures, recall prevalence is the most stable across the studies as the comparative scale (ie, period of recall) is standardized.

Recall prevalence is described in terms of the period of recall required: -- 1-week prevalence is the proportion of the population who experienced symptoms over the week preceding the questioning.-- 1-month prevalence is the proportion of the population who experienced symptoms over the month preceding the questioning.-- 1-year prevalence is the proportion of the population who experienced symptoms over the 12 months preceding the questioning.-- Lifetime prevalence is the portion of the population who experienced symptoms at any stage of their life preceding the questioning.

Whilst point prevalence refers to pain at the time of the assessment, some authors have taken a broader view and include 1-week prevalence data within their definition of point prevalence.[@b21-jpr-3-057]

The ability of subjects to accurately report on their pain prevalence over any of these periods will depend on their ability to recall the pain.[@b19-jpr-3-057] A number of factors may influence the optimal period over which to collect data in determining the prevalence of ALBP in a community.

Memory decay is a term used to describe the gradual memory loss that occurs over time when recalling significant events.[@b22-jpr-3-057] Three factors determine the extent to which memory decay will affect the data collected on ALBP prevalence: (a) the longer the time period of recall the greater the potential influence of memory decay, (b) the more significant the incident the less likely that memory decay will occur, and (c) the innate ability of the individual to recall events will influence the rate of memory decay.

Forward telescoping describes the tendency for a subject to recollect events, such as LBP, as occurring more recently than they actually did.[@b22-jpr-3-057] An example would be an adolescent who had an episode of LBP two years ago, but who includes it within 1-year prevalence data. This will tend to increase the reported prevalence of LBP when investigating period prevalence, particularly over shorter time periods.

The shortest period of recall is pain at the time of data collection, ie, point prevalence. However, too short a period of recall may limit the ability to collect data from sufficient subjects to develop an understanding of the risk factors associated with ALBP. This is counterbalanced by the notion that collection of data on ALBP reported at the time of questionnaire delivery will significantly reduce the potential for memory decay to affect the data validity.

The longest period of recall is lifetime prevalence, where the subject is asked if they have had any episode of LBP. The use of lifetime prevalence will negate the influence of forward telescoping, however memory decay presents a significant influence.

It remains unclear what is the most valid or reliable period prevalence to use for the collection of ALBP prevalence rates, however, due to the stable nature of recall prevalence definition across the literature, this measure will be used in this review to compare the potential effect of differing ALBP definitions on prevalence rates.

Material and methods
====================

Literature search
-----------------

The electronic databases of MEDLINE, EMBASE, and CINAHL were searched using the Medical Subject Headings: Adolescent, Low Back, Pain, and the keywords: adolescent, children, low back pain, spinal pain, lumbar pain. Bibliographies of relevant articles were manually searched. No age restrictions were applied to the search strategy.

Inclusion criteria
------------------

No attempt was made to exclude studies based on study quality. Articles were included if they were in English language and available in full text. Studies were excluded if they did not specifically describe the low back area, did not focus on adolescents (aged between 10 and 19 years), were focused on specific causes of ALBP (ie, related to backpack carriage), or related to specific adolescent subpopulations (ie, athletes).

Analysis
--------

All articles were reviewed for the description of ALBP used. This definition was either stated directly in the paper or was extrapolated from the questions used to collect ALBP data. The definitions were then collated and characterized into three groups, based on their defining characteristics: General ALBP: any ALBP, ie, there were no restrictions placed on the reported ALBP.Chronic/recurrent ALBP: low back pain that was characterized by a measure of chronicity or recurrence.Severe/disabling ALBP: low back pain that was characterized by a measure of severity, ie, effect on activity.

ALBP prevalencedata from each study by recall prevalence was recorded in an Excel^©^ (Microsoft Corporation, Redmond, WA) spreadsheet for further analysis.

Results
=======

Article selection
-----------------

The initial literature search yielded 89 citations. These articles were screened for relevance and content. Of those, 42 did not meet eligibility criteria, leaving 47 articles which underwent detailed review. The main reasons for failing to meet eligibility criteria was a failure to define the area of the low back, a focus on specific subgroups of adolescents (athletes, dancers), and failure to specifically present prevalence rates for subjects between the ages 10 to 19 years of age. Of the 47 articles selected three involved re-analysis of data presented in a previous study, and were therefore not included in the prevalence review. [Table 2](#t2-jpr-3-057){ref-type="table"} and [Figure 1](#f1-jpr-3-057){ref-type="fig"} present the characteristics of the included studies.

Due to the small number of subjects that presented ALBP prevalence data once broken down by gender and chronological age, the data for average prevalence for both male and female over the recall periods were used in this review.

[Table 3](#t3-jpr-3-057){ref-type="table"} presents the definitions for ALBP used in the studies identified in this review, and the subsequent groupings of the ALBP type based on the definition used.

[Table 4](#t4-jpr-3-057){ref-type="table"} presents the prevalence rates reported in the studies, by period prevalence and ALBP category. These prevalence rates are summarized in [Table 5](#t5-jpr-3-057){ref-type="table"}.

General ALBP was the most common definition of ALBP from the literature reviewed, and therefore presented the most data for each period prevalence. The 1-week, 1-month, and 1-year prevalence rates for this category of ALBP were graphed against a 12-month timeline, and a logarithmic trend line applied to these points. As the relationship between period prevalence rates was not expected to be linear, ie, a 'ceiling effect' was expected over an extended period, a logarithmic trend line was used to describe the relationship between period prevalence rates over the 12-month period.

The logarithmic trend line for general ALBP over the 12-month period and the corresponding correlation coefficient is presented below (where y = prevalence rate (%), and x = weeks). $$\text{General}\,\text{ALBP}:\text{y} = 7.2149\text{ln}(\text{x}) + 17.978\,\text{R}^{2} = 0.87$$

Discussion
==========

This review identified that within the literature related to the prevalence of low back pain amongst adolescents, there were a range of definitions used. When these definitions were classified into three broad categories they represented different prevalence rates.

The particular concern identified by this study was that most papers reported their adolescent subjects as suffering low back pain, without consideration of the definitional parameters. This constrains the ability to synthesize the literature to identify risk factors, as studies with different pain definitions (in terms of severity, chronicity, and intensity) lack homogeneity, as they are describing different pain situations.[@b16-jpr-3-057] Within each of the three broad classifications used in this review, there were significant differences in the period prevalence rates across studies, suggesting a wide variation in ALBP prevalence rates.

The logarithmic trend line calculated in this paper represents the behavior of the average ALBP prevalence rate for each period recall from the literature available. As more studies are published, which present prevalence data for each category of ALBP, the robustness of this formula should improve. This trend line can be seen to represent the 'natural' history of ALBP within a normal adolescent population. As the robustness of this formula improves, it presents a unique measure to review the success of any intervention aiming to reduce the prevalence of ALBP.

Whilst all of these studies reported on the prevalence of ALBP, the differing definitions used mean that they may be referring to different forms of ALBP. When attempting to identify risk factors it seems prudent to ensure that the form of ALBP is the same across the population studied. When collating and analyzing evidence from the literature, it is important to compare "apples with apples, and oranges with oranges." In the situation described in this paper, it is not certain that this is currently the case with ALBP.

It remains unclear whether the different definitions refer to different forms of ALBP, or to different points along a continuum of one form of ALBP. Whilst general ALBP reflects any low back pain, chronic/recurrent ALBP and severe/disabling ALBP represents pain of a specific form.

Five examples of question wording are provided below: Any ache, pain, or discomfort in the lower backAny pain in the low backLow back pain lasting for one day or longerPain in the low back at least weeklyLow back pain that that interfered with school, work, or leisure activities.

These five different definitions would seem to refer to different types of ALBP.

Whilst some studies have attempted to define ALBP in terms of chronicity, severity, frequency, or episode duration, they have often failed to provide a well defined set of parameters for each measure. For example, chronicity is widely used in both the adult and adolescent LBP research literature, however it remains a poorly defined term that lacks consensus.[@b20-jpr-3-057] Chronicity can be viewed on a continuum, from an always present condition at one end through to a condition that recurs regularly at the other. Diepenmaat et al[@b28-jpr-3-057] defined ALBP as greater than four days per month of pain, and ignored any report of ALBP less than three days ALBP per month. In the Mikkelson et al[@b61-jpr-3-057] definition, for a person to be considered to have ALBP they must have had it for at least once a week over the previous three months. Failure to report weekly pain over a three month period classified the subject as having no pain.

Feldman et al[@b31-jpr-3-057] used a definition of ALBP as low back pain reported by adolescents which occurred at least once a week for six months. Anything less than this was deemed to be 'transient, inconsequential' pain. Alternatively, Hakala et al[@b34-jpr-3-057] included those subjects reporting monthly low back pain in the previous six months in the group without ALBP. Statements such as, "It is probable that a single attack of mild LBP once a year has no particular significance for one's health status,"[@b33-jpr-3-057] remain unsubstantiated.

None of the studies, which classified ALBP according to chronicity, severity, or frequency, provided any justification for these classifications. Whilst all of the studies reviewed described their adolescent subjects as having low back pain, it would facilitate discussions if the description included consideration of the category of ALBP. [Table 5](#t5-jpr-3-057){ref-type="table"} indicates that over the period prevalence rates the reported rate of chronic/recurrent or severe/disabling ALBP (ie, where a definition involved a criterion of recurrences or effects on activities of daily living) were lower than that for the general ALBP.

The period over which the subjects have been asked to recall any episodes of ALBP also varied significantly between studies.

In this review, there was little difference between the average lifetime prevalence (53%) and the 1-year prevalence (53.9%) of general ALBP. The longer the duration of recall the greater the potential for forgetfulness with extensive periods potentially providing unreliable data.[@b16-jpr-3-057] It is more likely in lifetime prevalence data that the results are more reflective of significant episodes, rather than less limiting or less severe episodes.

Burton et al[@b26-jpr-3-057] found a high level of forgetfulness of previous LBP (1-year prevalence) in a group of 216 schoolchildren studied over the five years of their secondary schooling. Almost 60% of the students who reported LBP forgot at least one previous episode of spinal pain during annual questioning. This study suggested that with the use of a 1-year recall period, the influence of memory decay may significantly affect the accuracy of the prevalence data.

The effect of memory decay on the lifetime prevalence rate appears less significant for chronic/recurrent or severe/disabling ALBP. This difference between general ALBP and the other two categories may reflect the influence of a 'saliency rule', where more significant episodes are remembered more than less significant events.

Conclusion
==========

This review of the ALBP prevalence literature identified a range of definitions used to define low back pain in adolescents.

The review of the ALBP prevalence data identified that the prevalence rates differed between three categories of ALBP definitions, ie, general ALBP, chronic/recurrent ALBP, and severe/disabling ALBP. It remains unclear how the three categories are related. Each category of ALBP may have different risk factors, which require further investigation.

For all types of ALBP, there appears to be a steady increase in average prevalence rates with the passing of time. For general ALBP this represented a relationship over 12 months represented by the equation y = 7.274 ln(x) + 17.68 R^2^ = 0.792 (where y = prevalence rate (%), and x = weeks).

There did not appear to be significant difference between lifetime prevalence and 12-month prevalence in general ALBP, however for severe/disabling and chronic/recurrent ALBP a greater variation between the two prevalence rates was identified, potentially reflecting the effect of a saliency rule.

Differences in prevalence rates between the three categories of ALBP used in this review suggests that definitions of ALBP need to be standardized across studies, particularly in the search for risk factors. This will promote better homogeneity of studies into ALBP, allowing a stronger meta-analysis of the observational studies, and a better understanding of this condition.

Consideration of a classification system for ALBP will facilitate communication between the epidemiological and the clinical streams of ALBP research.

The most consistent reporting of ALBP appears to be for general ALBP, reported in period prevalence rates of 12 months or less.
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###### 

Potential causes for ALBP

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Primary spinal disorders** Mechanical Disc lesions or herniationsSpondylolysis and spondylolisthesisScheuermanns diseaseOveruse injuriesTraumatic injuriesCongenital disorders -- scoliosis, spinal fusion, spinalstenosisInflammatory/Infectious DiskitisDisc calcificationsInflammatory rheumatic disordersInfections of the bone/soft tissueArachnoiditisNeoplasms Benign tumors -- osteoid osteoma, osteochondroma, lipoma, giant cell tumor,Malignant tumors -- Ewings sarcoma, osteogenic sarcoma, neuroblastoma, cord tumorsRadiation Therapy sequalae**Systemic or nonspinal diseases** Hematolgic disorders -- sickle cell, leukemia, Hodgkin's, and non-Hodgkin's lymphomaAortic dissectionIntra-abdominal diseasesFibrositisMarfans diseasePsychological**Nonspecific causes**
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** Adapted from Balague and Nordin,**[@b17-jpr-3-057]** and King.[@b18-jpr-3-057]

###### 

Characteristics of the studies presenting ALBP prevalence data used in this review

                                                                                                        **Studies**   **Subjects**             
  ------------------------------------------------------------------------------------------ ---------- ------------- -------------- --------- ------
  Origin of study sample                                                                     European   34            77             267,976   96.3
  Middle East                                                                                2          4.6           5,400          1.9       
  Australasia                                                                                3          6.8           2,124          0.8       
  Americas                                                                                   3          6.8           1,879          0.7       
  Africa                                                                                     2          4.6           826            0.3       
  Data collection methodology                                                                School     40            91             60,083    21.6
  National Survey                                                                            4          9             218,122        78.4      
  Period recall (% add up to greater than 100 as some studies use multiple recall periods)   PP         14            31.8           21,737    7.8
  1M                                                                                         15         34.1          15,503         5.6       
  3M                                                                                         3          6.8           4,871          1.8       
  6M                                                                                         6          13.6          206,988        74.4      
  1Y                                                                                         12         27.3          36,935         13.3      
  LT                                                                                         20         45.5          38,247         13.7      

**Abbreviations:** ALBP, adolescent low back pain; PP, point prevalence; 1W, 1-week; 1M, 1-month; 3M, 3-month; 6M, 6-month; 1Y, 1-year; LT, lifetime.

###### 

Characteristics of the studies presenting ALBP prevalence data used in this review

  **Study**                                                                                                                                                                                                                                                                                                                   **Definition**                                                                                                                                                                                       **ALBP grouping**
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------
  Grimmer and Williams,[@b32-jpr-3-057] Cakmak et al,[@b27-jpr-3-057] Legg et al,[@b8-jpr-3-057] Mogensen et al,[@b44-jpr-3-057] Wedderkop et al,[@b60-jpr-3-057] Balague et al,[@b25-jpr-3-057],[@b4-jpr-3-057],[@b21-jpr-3-057] Prista et al,[@b49-jpr-3-057] Harreby et al,[@b33-jpr-3-057] Shehab et al[@b51-jpr-3-057]   Any pain in the low back.                                                                                                                                                                            General
  Watson et al,[@b58-jpr-3-057] Murphy et al,[@b45-jpr-3-057],[@b46-jpr-3-057] Jones et al[@b35-jpr-3-057],[@b38-jpr-3-057]                                                                                                                                                                                                   Low back pain lasting for one day or longer.                                                                                                                                                         General
  Auvinen et al[@b23-jpr-3-057]                                                                                                                                                                                                                                                                                               Any pain or aching in the low back area.                                                                                                                                                             General
  Olsen et al[@b47-jpr-3-057]                                                                                                                                                                                                                                                                                                 Pain or other trouble with the lower part of the back.                                                                                                                                               General
  Sjolie[@b53-jpr-3-057]                                                                                                                                                                                                                                                                                                      Pain, ache, or discomfort in the lower back, not related to trauma or menstrual pain.                                                                                                                General
  Ebrall,[@b19-jpr-3-057] Skoffer and Foldspang[@b54-jpr-3-057]                                                                                                                                                                                                                                                               Any pain or discomfort in the low back.                                                                                                                                                              General
  Mierau et al[@b43-jpr-3-057]                                                                                                                                                                                                                                                                                                Pain, soreness, or hurt over the low back.                                                                                                                                                           General
  Kristensen et al[@b40-jpr-3-057]                                                                                                                                                                                                                                                                                            Any ache, pain, or discomfort in the lower back.                                                                                                                                                     General
  Jones et al[@b37-jpr-3-057]                                                                                                                                                                                                                                                                                                 Any low back pain or pain occurring regularly.                                                                                                                                                       General, Chronic/recurrent
  Vikat et al[@b57-jpr-3-057]                                                                                                                                                                                                                                                                                                 Pain in the low back at least weekly.                                                                                                                                                                Chronic/recurrent
  El-Metwally et al,[@b29-jpr-3-057] Mikkelson et al[@b61-jpr-3-057]                                                                                                                                                                                                                                                          Any pain or ache in the low back -- paper reported on monthly or weekly recurrence only.                                                                                                             Chronic/recurrent
  Feldman et al[@b30-jpr-3-057],[@b31-jpr-3-057]                                                                                                                                                                                                                                                                              Low back pain with a frequency of at least once per week.                                                                                                                                            Chronic/recurrent
  Hakala et al[@b34-jpr-3-057]                                                                                                                                                                                                                                                                                                Back pain at least weekly over the past half a year.                                                                                                                                                 Chronic/recurrent
  Diepenmaat et al[@b28-jpr-3-057]                                                                                                                                                                                                                                                                                            Pain lasting a day or longer with \>4 days per month.                                                                                                                                                Chronic/recurrent
  Taimela et al,[@b2-jpr-3-057] Kujala et al[@b41-jpr-3-057]                                                                                                                                                                                                                                                                  Low back pain that interfered with school, work, or leisure activities.                                                                                                                              Severe/disabling
  Masiero et al[@b42-jpr-3-057]                                                                                                                                                                                                                                                                                               Any nonoccasional pain that in some way limited the student in daily activities.                                                                                                                     Severe/disabling
  Burton et al[@b26-jpr-3-057]                                                                                                                                                                                                                                                                                                Quite bad pain, other than occasional twinges.                                                                                                                                                       Severe/disabling
  Prendeville and Dockrell[@b48-jpr-3-057]                                                                                                                                                                                                                                                                                    An episode of low back pain and/or discomfort that interrupted normal daily activities and/or required treatment. Low back pain due to any structural abnormalities or menstrual pain is excluded.   Severe/disabling

###### 

Period prevalence rates for each category of ALBP

  **Study**                                                                                        **Prevalence (%)**                               
  ------------------------------------------------ ----------------------------------------------- -------------------- ------ ------ ------ ------ --
  **General low back pain**                        Auvinen et al[@b23-jpr-3-057]                                                      39            
  Balague et al[@b4-jpr-3-057]                     13                                                                                        40     
  Balague et al[@b21-jpr-3-057]                    9.4                                                                                       32.5   
  Balague et al[@b24-jpr-3-057]                                                                                                              20     
  Balague et al[@b25-jpr-3-057]                                                                                                              51     
  Bejia et al[@b36-jpr-3-057]                      13                                                                                        28.4   
  Cakmak et al[@b27-jpr-3-057]                                                                                                               32     
  Ebrall[@b19-jpr-3-057]                           16.7                                                                                      57     
  Grimmer and Williams[@b32-jpr-3-057]             25.4                                                                                             
  Harreby et al[@b33-jpr-3-057]                    13.9                                            30.6                               50.8   58.9   
  Jones et al[@b35-jpr-3-057]                                                                      18.6                                             
  Jones et al[@b37-jpr-3-057]                      15.5                                                                                      40.2   
  Jones et al[@b38-jpr-3-057]                                                                      25.4                                             
  Kjaer et al[@b39-jpr-3-057]                                                                      22                                               
  Kovacs et al[@b50-jpr-3-057]                     25                                                                                        61     
  Kristensen et al[@b40-jpr-3-057]                                                                                                           63     
  Legg et al[@b8-jpr-3-057]                                                                                                                  48     
  Mierau et al[@b43-jpr-3-057]                                                                                                 33                   
  Mogensen et al[@b44-jpr-3-057]                                                                   40                                               
  Mohseni-Bandpei et al[@b62-jpr-3-057]            15                                              14                          15.6   17.4          
  Murphy et al[@b45-jpr-3-057]                     20                                              36                                               
  Murphy et al[@b46-jpr-3-057]                                                                     22                                        55     
  Olsen et al[@b47-jpr-3-057]                                                                                                         22     30.4   
  Prista et al[@b49-jpr-3-057]                                                                                                               58     
  Shehab et al[@b51-jpr-3-057]                     35                                                                                        57.8   
  Sjolie[@b52-jpr-3-057],[@b53-jpr-3-057]                                                                                             57            
  Skoffer and Foldspang[@b54-jpr-3-057]                                                                                 51.3          60.3   64.8   
  Staes et al[@b55-jpr-3-057]                                                                      38                                               
  Troussier et al[@b56-jpr-3-057]                  23                                                                                               
  Van Gent et al[@b63-jpr-3-057]                                                                   46.5                                             
  **Recurrent**                                    Watson et al[@b58-jpr-3-057],[@b59-jpr-3-057]                        23.9                        
  Wedderkopp et al[@b60-jpr-3-057]                                                                 14.8                                             
  Diepenmaat et al[@b28-jpr-3-057]                                                                 7.5                                              
  El-Metwally et al[@b29-jpr-3-057]                                                                                     22.4                        
  Feldman et al[@b30-jpr-3-057],[@b31-jpr-3-057]                                                                               24.9                 
  Balague et al[@b25-jpr-3-057]                                                                                                              48     
  Jones et al[@b37-jpr-3-057]                                                                                                         13.1          
  Prista et al[@b49-jpr-3-057]                                                                     12                                 13.5   28     
  Shehab et al[@b51-jpr-3-057]                                                                                                               36     
  Staes et al[@b55-jpr-3-057]                                                                      3                                                
  Sjolie[@b53-jpr-3-057]                                                                                                              32            
  Vikat et al[@b57-jpr-3-057]                                                                                                  27                   
  Hakala et al[@b34-jpr-3-057]                                                                                                 11.7                 
  **Disabling**                                    Kristensen et al[@b40-jpr-3-057]                                                          22     
  Skoffer and Foldspang[@b54-jpr-3-057]                                                                                 24.2                        
  Kujala et al[@b41-jpr-3-057]                                                                                                        10.7          
  Masiero et al[@b42-jpr-3-057]                                                                                                       20.5          
  Prendeville and Dockrell[@b48-jpr-3-057]         17                                                                                 28     41.5   
  Taimela et al[@b2-jpr-3-057]                                                                                                        14.2          
  Kjaer et al[@b39-jpr-3-057]                                                                      8                                                
  Balague et al[@b25-jpr-3-057]                                                                    24.3                                             
  Burton et al[@b26-jpr-3-057]                     7                                                                                         30     

**Abbreviations:** ALBP, adolescent low back pain; PP, point prevalence; 1W, 1-week; 1M, 1-month; 3M, 3-month; 6M, 6-month; 1Y, 1-year; LT, lifetime

###### 

Summary of period prevalence rates for each category of adolescent low back pain

                                             **Prevalence rates (%)**              
  -------------------- --------------------- -------------------------- ---------- ------
  0--1 week            Average (50th %ile)   16.1                       12         N/A
  Range (%min--%max)   9.4--35               7--17                      N/A        
  No of Studies        12                    2                          N/A        
  1-month              Average (50th %ile)   24.65                      16.15      7.5
  Range (%min--%max)   14--46.5              8--24.3                    3--12      
  No of Studies        12                    2                          3          
  3-month              Average (50th %ile)   51.3                       24.2       22.4
  Range (%min--%max)   51.3                  24.2                       22.4       
  No of Studies        1                     1                          1          
  6-month              Average (50th %ile)   33                         N/A        24.9
  Range (%min--%max)   15.6--39              N/A                        11.7--27   
  No of Studies        3                     N/A                        3          
  12-month             Average (50th %ile)   50.8                       20.5       13.5
  Range (%min--%max)   17.4--60.3            10.7--28                   13.1--32   
  No of Studies        5                     5                          3          
  Lifetime             Average (50th %ile)   51                         35.75      36
  Range (%min--%max)   20--64.8              30--41.5                   28--48     
  No of Studies        17                    2                          3          
